AuopouliosM. A., GoldhaberP., MunsonP. L.: Thyrocalciotonin inhibition of parathyroid hormone in tessue culture. Science, 151; 330 (1966).
2.
AlkenG. E., HermannG., WeberF.: Zschr. Urol., 50; 423 (1957).
3.
AlpiM., PatiV.: Contribute alla terapia medica della calcolosi urinaria con un nuovo farmaco ad azione polivalente. Quad. Urol., XI, n. 41961.
4.
ArcherH. E., DormerA. E., ScowenE. F., WattsR. W. E.: Primary hyperoxaluria. Lancet, 2; 320–322 (1957).
5.
ArcherH. E., DormerA. E.: The aetiology of primary hyperoxaluria. Brit. Med. J., 1; 157 (1958).
6.
ArcherH. E.: Studies on the urinary excretion of oxalate by normal subjects. Clin. Sci., 16; 405 (1961).
7.
ArdaillonR., SlamaR., RichetG., BernardJ.: Uricémie et excrétion urinaire de l'acide urique au cours de leucoses aiguës. Rev. Franç. Clin. Biol., 5; 590 (1960).
8.
AtkinsG. L., DeanB. M., GriffinW.J., ScowenE. F., WattsR. W. E.: Primary hyperoxaluria. The relation between ascorbic acid and the increased urinary excretion of oxalate. Lancet, 2; 1096–1097 (1963).
9.
BakerR., SisonF.: Demonstration of altered tissue mucopolysaccarides in renal-calculus disease by selective staining techniques. J. Urol., 72; 103 (1954).
10.
BakerR., ReavenG., SawyerJ.: Ground substance and calcification. J. Urol., 71; 54 (1954).
11.
BenningtonJ. L., HaberS. L., SmithJ. V., WarnerN. E.: Crystals of calcium oxalate in the human kidney. Studies by means electron microbe and X-ray diffraction. Amer. J. Clin. Pat., 41; 8–14 (1964).
12.
BoyceW. H., PoolCh. S., HeuschallI., KingJ. R.: Organic matrix of urinary calculi. Acta Radiol., 50; 543 (1958).
13.
BoyceW. H., KingG. S.: Present concept concerning the origin of matrix and stones. Ann. N.Y. Accad. Sci., 104; 563 (1963).
BracciU., CapraP., MianoL.: La calcolosi renale. Moderni orientamenti etiopatogenetici e terapeutici. Chir. Urol., 10; 415 (1968).
16.
BussolatiG., PearseA. G. E.: Immunofluorescent localization of calciotonin in the «C» cells of pig and dog thyroid. J. Endocr., 37; 205 (1967).
17.
CarboneG.: In tema di nefropatie litiasiche. Rass. clin.-scient., 43; ottobre (1967).
18.
CarboneG.: La calcolosi recidiva (su alcuni aspetti patogenetici della litiasi recidiva prerenale). Soc. Med. Chir. romana. Seduta dell'8–5–1970.
19.
CattelW. R.: Mechanism of renal excretion of oxalate in the dog. Clin. Sci., 22; 43 (1962).
20.
ChawallaR.: On the therapy of hyperoxaluria and so-called idiopathic hypercalciuria. J. Urol., 7; 421 (1963).
21.
ChouL. Y., DonohueW. L.: Oxalosis: possible «inborn error of metabolism» with nephrolithiasis and nephrocalcinosis due to calcium oxalate as the predominating features. Pediatrics, 10; 660–666 (1952).
CrawhallJ. C.: The oxalate contents of human plasma. Clin. Sci., 20; 357 (1961).
24.
DanielsR. A.: Familial hyperoxaluria. Am. J. Med., 29; 820 (1960).
25.
DavisJ. S., KlingbergW. G., StowellR. E.: Nephrolithiasis and nephrocalcinosis with calcium oxalate crystals in kidneys and bones. J. Pediat., 36; 323–334 (1950).
FidalgoB.: La proteinuria en la litiasis renal. Rev. de Med. Navarra (1964).
32.
FidalgoB.: Mezzi terapeutici per il trattamento patogenetico della litiasi renale (osservazioni cliniche con il prodotto Nefrolitin). Arch. Esp. Urol., (1964).
33.
FleischH., BisazS.: Mechanism of calcification: inhibitory role of pyrophosphate. Nature, 195; 94 (1962).
34.
FleischH., BisazS.: Isolation from urine of ortophosphate on urinary pyrosphosphate excretion and the prevention of urolithiasis. Amer. J. Physiol., 203;
35.
FosterG. V., Mac IntyreI., MelvinK. E. W., JoplinG. S., SlackE.: Effect of thyrocalciotonin in man. Lancet, 1; 107 (1966).
36.
FosterG. V., Mac IntyreI., PearseA G. E.: Calciotonin production and the mitochondrion rich cells of the dog thyroid. Nature, 202; 1303 (1964).
37.
FrederickE. W., RabkinM. T., SmithL. H.: Primary hyperoxaluria: a defect in glyoxylate metabolism. 54th Annual Meeting Amer. Soc. Clin. Invest., (1962).
38.
FrederickE. W.: Studies on primary hyperoxaluria: demostration of defect in glyoxylate metabolism. New Engl. J. Med., 9; 269 (1963).
39.
FriesD.: A propos d'une observation d'oxalose. J. d'Urol., 69; 647 (1963).
40.
GarrodA. E.: Inborn errors of metabolism.London, Oxford Univ. Press (1923).
41.
GershoffS. N., AndrussS. B.: Dietary magnesium, calcium and vitamin B6 and experimental nephropaties in rats calcium oxalate calculi, apatite nephrocalcinosis. J. Nutr., 73; 308 (1961).
42.
GiglioV., VinciguerraA.: Correlazioni tra pH, acidità titolabile e potere tampone urinario nella litiasi urica, nella litiasi urica con gotta e nella litiasi ossalica. In corso di stampa.
43.
GiglioV.: Litiasi urica e sua terapia medica. In corso di stampa.
HammarstenG.: Eine experimentelle Studie über Calcium oxalat als Steinbildner in dem Harnwegen: speziall mit Trucksich auf die Bedentung der Magnesium. Lunds Universites Arsskrit., 32; 12 (1937).
46.
HammarstenG.: On calcium oxalate stones.Thomas Publ., Springfield (1956).
HodgkinsonA.: The urinary excretion of oxalic acid in nephrolithiasis. Proc. Roy. Soc. Med., 1; 970 (1958).
49.
HodgkinsonA., PirathL. H.: The urinary excretion of calcium and inorganic phosphate in 344 patients with calcium stone of renal origin. Brit. J. Surg., 46; 10 (1958).
50.
KhouriG.: Physiopatologie de l'acide oxalique chez l'homme.Masson, Parigi (1948).
51.
LangrueG., MandatM. H., MeyerPh., SapirM., MilliezP.: Oxalose familiale avec acidose hyperclorémique secondaire. Sem. Hôp. Paris, 35; 2023 (1959).
52.
LegrainM., PrumierPh., GuedonJ., Wacsner: Oxalose. Rein et foie, 9 (1966).
LudwigG. D.: Renal calculi associated with hyperoxaluria. Ann. N.Y. Accad. Sci., 104; 621–637 (1963).
57.
ManfrediG. C.: Iperossaluria ed ossalosi. In malattie del ricambio, I-XXVIII, 1–1279, Casa Ed. Ambrosiana, Milano (1965).
58.
MarshallV. F.: Oxalosis. J. Urol., 82; 278 (1959).
59.
McIntoshJ. F., ReadM. K.: Oxalic acid excretion in oxalate lithiasis. J. Urol., 80; 272 (1958).
60.
MclaurinA. W.: Primary hyperoxaluria. Ann. Intern., 55; 70 (1961).
61.
MianoL., ArachiN., CammaranoR.: La litiasi urica oggi; problemi di diagnosi e di terapia. Chir. urol., 8; 293 (1966).
62.
MilhaudG., MoukhatarM. S.: Thyrocalciotonin: effects on calcium kinectics in the rat. Proc. Soc. Exper. Biol. Med., 123; 207 (1966).
63.
MooreC. A., BurgeG. E.: Reduction in frequency of renal calculus formation by oral magnesium administration; a preliminary report. Invest. Urol., 2; 7 (1964).
64.
MuglerA.: Étude de l'oxalurie de 24 heures dans la lithiase oxalique. Rein et foie, 4; 179 (1962).
65.
NakadaH. I., FriedmannB., WeinhouseS.: Pathwais of glycine catabolism in rat liver. J. Biol. Cherri., 216; 583 (1955).
PaementierR., DuretR.: Oxalose idiopathique de l'adulte. Ann. Anat. Pat., 6; 99 (1961).
70.
PyrahL. N.: A case of oxalate nephrocalcinosis and primary hyperoxaluria. Brit. J. Urol., 31; 235 (1959).
71.
RusselR. G., HodgninsonA.: The urinary excretion of inorganic pyrophosphate by normal subjects and patients with renal calculus. Clin. Sci., 35; 51 (1966).
72.
ScowenE. F., CrawhellJ. C., WattsR. W.: Incorporation of carboxylcarbon atom of glicyne into oxalate in case of primary hyperoxaluria. Lancet, 2; 300 (1958).
73.
ScowhenE. F., StansfeldA. C., WattsR. W. E.: Oxalosis and primary hyperoxaluria. J. Path. Bact., 77; 195 (1959).
74.
ShepardT. H., CreigthonS. A., KrebsE. G., LeeL. S., ThulineH. G.: Primary hyperoxaluria. I: Clinical and pathological findings in a patient with calcium oxalate nephrocalcinosis. Pediatrics, 25; 582–591 (1960).